---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-022880"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2026-07-07T12:45:22+00:00"
generated_at: "2026-07-07T12:50:43.331627+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BIO-key regains Nasdaq compliance; trading resumes July 8 after hearing panel decision

## Summary
- Nasdaq Hearings Panel determined BIO-key regained compliance with minimum bid price and SEC filing requirements.
- Trading of BKYI common stock resumes on Nasdaq Capital Market on July 8, 2026.
- Company subject to Discretionary Panel Monitor for one year until July 6, 2027.
- CEO cites growing recurring revenue, solid financial position, and expects significantly improved results in 2026.

## SEC filing metadata
- accession: 0001437749-26-022880
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2026-07-07T12:45:22+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774926022880/0001437749-26-022880-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774926022880/bkyi20260706c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-022880
- JSON: https://secwatch.observer/filing/0001437749-26-022880.json
- Plain text: https://secwatch.observer/filing/0001437749-26-022880.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.